Corpus Intelligence IC Memo — UBH OF OREGON LLD D/BA CEDAR HILLS 2026-04-26 08:50 UTC
IC Memo — UBH OF OREGON LLD D/BA CEDAR HILLS
Investment Committee Memorandum | OR | 98 beds | Grade C | EBITDA uplift $2.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UBH OF OREGON LLD D/BA CEDAR HILLS

CCN 384012 | MULTNOMAH, OR | 98 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

UBH OF OREGON LLD D/BA CEDAR HILLS is a 98-bed suburban community hospital in MULTNOMAH, OR with $32.5M in net patient revenue and a 3.0% operating margin. The hospital serves a payer mix of 11.5% Medicare, 2.9% Medicaid, and 85.6% commercial.

Thesis: Turnaround. Our ML models identify $2.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.0% to 10.3% (+736bps).

Net Revenue HCRIS$32.5M
Current EBITDA COMPUTED$972K
Operating Margin COMPUTED3.0%
Occupancy HCRIS80.5%
Revenue / Bed COMPUTED$332K
Net-to-Gross HCRIS44.0%
Distress Probability ML43.0%

2. Market Context & Competitive Position

63
OR Hospitals
-8.1%
State Median Margin
17
Comparable Hospitals

OR has 63 Medicare-certified hospitals with a median operating margin of -8.1%. The target's margin of 3.0% places it above the state median. Among 17 size-comparable peers (49-196 beds), the median margin is -12.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (49-196), prioritizing same-state peers. 17 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UBH OF OREGON LLD D/BA CEDAR H (Target)OR98$32.5M3.0%
GOOD SAMARITAN HOSPITAL CORVALOR169$466.4M-20.9%
LEGACY GOOD SAMARITAN HOSPITALOR177$415.0M-10.6%
ADVENTIST MEDICAL CENTER-PORTLOR168$324.3M-14.1%
TUALITY HEALTHCAREOR113$268.5M-13.1%
LEGACY MERIDIAN PARK HOSPITALOR123$265.2M-0.4%
THREE RIVERS MEDICAL CENTEROR142$252.5M-12.4%
SKY LAKES MEDICAL CENTEROR90$251.4M-20.9%
MCKENZIE-WILLAMETTE HOSPITALOR113$247.7M-2.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$683K+210bp18mo
Cost to Collect4.5%2.5%$651K+200bp12mo
Denial Rate Reduction12.0%6.5%$644K+198bp12mo
A/R Days Reduction5200.0%3800.0%$396K+122bp9mo
Clean Claim Rate88.0%96.0%$21K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$683K
Cost to Collect
$651K
Denial Rate Reduction
$644K
A/R Days Reduction
$396K
Clean Claim Rate
$21K
Total EBITDA Uplift$2.4M
Current EBITDA$972K
+ RCM Uplift+$2.4M
Pro Forma EBITDA$3.4M
Current Margin3.0%
Pro Forma Margin10.3%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.5M$30.4M20.30x82.6%
Base (11x exit)10.0x11.0x$1.5M$33.9M22.66x86.7%
Bull Case9.0x11.0x$1.3M$42.3M31.41x99.2%
Bull (12x exit)9.0x12.0x$1.3M$46.5M34.56x103.1%
Bear Case11.0x10.0x$1.6M$17.9M10.88x61.2%
Bear (11x exit)11.0x11.0x$1.6M$20.2M12.29x65.2%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 17 hospitals with 49-196 beds
  • Same-state prioritization (n=18)
  • Comp margins: P25=-18.2% / P50=-12.2% / P75=-9.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.